Virtual Reality and Biofeedback for Chronic Dizziness in Adolescents
This study is looking at a new way to help young people, aged 13 to 25, who experience chronic dizziness, including conditions like Persistent Postural Perceptual Dizziness (PPPD) and Vestibular Migraine. It combines standard treatments like biofeedback, systematic desensitization, and cognitive behavioral therapy with virtual reality (VR) technology. The goal is to see if adding VR can improve dizziness symptoms and quality of life. Researchers will measure how much dizziness affects daily life, overall quality of life, and other dizziness-related symptoms after one year. This study is for those who haven't yet received these specific treatments for their chronic dizziness. The study plans to enroll 12 participants, but its current status is unclear.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 12 participants aged 13 to 25.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one year to measure changes in dizziness and quality of life.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jacob R Brodsky, MD · PRINCIPAL_INVESTIGATOR · Boston Children's Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Dizziness Handicap Inventory1 year
A 25-item self-assessment that quantifies the impact of dizziness on daily functioning. The DHI measures self-perceived handicap due to dizziness in the functional, emotional, and physical domains. Higher score corresponds to a greater perceived handicap due to dizziness.
- Nijmegen Questionnaire1 year
A 16-item self-report questionnaire to assess hyperventilation syndrome. Participants are asked to rate the occurrence of 16 symptoms commonly associated with hyperventilation syndrome on a 5-point Likert scale (0-Never; 4-Very often). Scores range from 0 to 64, with higher score indicating worse outcome. A score greater than 23 suggests positive diagnosis of hyperventilation syndrome.
- Pediatric Quality of Life Inventory1 year
A 23-item inventory that measures health-related quality of life. The PedsQL consists of 4 scales: physical, emotional, social, school. Participants rate how often each item has been a problem for them within the past month on a 5-point Likert scale (0-Never; 4-Almost always). Higher score suggests lower health-related quality of life.
- Fear of Pain Questionnaire1 year
A 23 or 24-item (depending on self-report or parent-proxy version) questionnaire that assesses pain-related fears. Participants are asked to rate each item on a 5-point Likert scale (0-Strongly Disagree; 4-Strongly Agree). Higher score suggests a higher level of pain-related fears.
- Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Measure1 year
An 8-item self-report measure that screens for an quantifies the severity of anxiety symptoms. Participants rate the frequency of each item within the past seven days on a 5-point Likert scale (1-Never; 5-Almost always). A higher score suggests a higher severity of anxiety.
- Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Measure1 year
An 8-item self-report measure that screens for and quantifies the severity of depression symptoms. Participants rate the frequency of each item within the past seven days on a 5-point Likert scale (1-Never; 5-Always). Higher score suggests a higher severity of depression.
- Niigata PPPD Questionnaire1 year
A 12-item self-reported measure intended to assess symptom severity, specifically for PPPD. Participants rate how much eat item has affected them in the past week on a 7-point Likert scale (0-None; 6-Unbearable). Scores range from 0 to 72, with higher scores indicating greater symptom severity.